Shares of Elite Pharmaceuticals, Inc. ELTP have lost 13.7% since the company reported earnings for the fiscal year ended March 31, 2026, underperforming the S&P 500 Index, which gained 1.8% over the same period. The stock has also trailed the broader market over the past month, declining 14.7% compared with the S&P 500’s 1.8% dip. … Read more
Can MRVL's AI Infrastructure Growth Outpace Its Margin Pressure?
The whipping post
Marvell Technology MRVL has been an important benefactor of AI infrastructure capex buildout. Marvell Technology has been transforming itself into a key contributor to the connectivity hardware solutions for AI infrastructure and data centers. Marvell Technology now expects its interconnect business to grow more than 70% year over year in fiscal 2027, supported by scale-out … Read more
Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 in the Second Half of 2026
The whipping post
Key Points The S&P 500 Growth index typically outperforms the regular S&P 500 because of its higher exposure to the powerhouse “Magnificent Seven” stocks. But these stocks, which include the likes of Nvidia and Alphabet, delivered a sluggish performance in the first half of 2026. I think the Magnificent Seven stocks will turn around over … Read more
SpaceX Joined 6 Stocks in the $2 Trillion Club. Here's My Top Pick for July.
Key Points Before the end of its first trading day on the Nasdaq, Elon Musk’s Space Exploration Technologies (NASDAQ: SPCX), or SpaceX, had joined an elite club: stocks with at least $2 trillion in market capitalization. The club is so exclusive that only six other stocks belong to it. And unlike SpaceX, most of them … Read more
Is Lam Research (LRCX) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock’s price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use … Read more